Detailed information for compound 1767997

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 336.77 | Formula: C16H17ClN2O4
  • H donors: 3 H acceptors: 5 LogP: 4.19 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(C[C@H](C(=O)O)NC(=O)c1nc(Cl)c2c(c1O)cccc2)C
  • InChi: 1S/C16H17ClN2O4/c1-8(2)7-11(16(22)23)18-15(21)12-13(20)9-5-3-4-6-10(9)14(17)19-12/h3-6,8,11,20H,7H2,1-2H3,(H,18,21)(H,22,23)/t11-/m1/s1
  • InChiKey: CWHGHTIGHBSZMS-LLVKDONJSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4429 0.9706 0.9706
Loa Loa (eye worm) hypothetical protein 0.4429 0.9706 0.9604
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4505 1 1
Echinococcus multilocularis 6 phosphofructo 2 kinase:fructose 2 0.4505 1 0.5
Entamoeba histolytica phosphoglycerate mutase family protein, putative 0.2659 0.2852 0.5
Mycobacterium ulcerans hypothetical protein 0.2659 0.2852 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4505 1 1
Mycobacterium ulcerans fructose-2,6-bisphosphatase GpmB 0.2659 0.2852 0.5
Giardia lamblia Hypothetical protein 0.2659 0.2852 0.5
Schistosoma mansoni 6-phosphofructokinase 0.4505 1 0.5
Giardia lamblia Hypothetical protein 0.2659 0.2852 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.4429 0.9706 0.9706
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4505 1 1
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.4429 0.9706 0.9706
Loa Loa (eye worm) hypothetical protein 0.4505 1 1
Onchocerca volvulus 0.4505 1 0.5
Trypanosoma brucei 6-phosphofructo-2-kinase 2 0.4429 0.9706 0.9706
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4505 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 94 uM Inhibition of Pseudomonas sp. AK1 BBOX assessed as hydroxylation of GBB to L-carnitine measured for 60 sec in presence of 2OG and Fe2+ by 1H NMR assay ChEMBL. No reference
IC50 (binding) > 1000 uM Inhibition of Pseudomonas sp. AK1 BBOX using GBBF as substrate after 10 mins in presence of 2OG and Fe2+ using TBS-protected fluorescein probe by fluoride release assay ChEMBL. No reference
Inhibition (binding) Inhibition of GBB binding to Pseudomonas sp. AK1 BBOX at 25 uM in presence of Mn2+ by 1H NMR GBB/2OG dual reporter displacement assay ChEMBL. No reference
Inhibition (binding) Inhibition of 2OG binding to Pseudomonas sp. AK1 BBOX at 25 uM in presence of Mn2+ by 1H NMR GBB/2OG dual reporter displacement assay ChEMBL. No reference
Kd (binding) = 103 uM Binding affinity to Pseudomonas sp. AK1 BBOX by intrinsic tryptophan fluorescence quenching assay ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.